Last 49.10 INR
Change Today 0.00 / 0.00%
Volume 0.0
BLIS On Other Exchanges
Symbol
Exchange
BLIS is not on other exchanges.
As of 7:05 AM 04/23/14 All times are local (Market data is delayed by at least 15 minutes).

bliss gvs pharma ltd (BLIS) Snapshot

Open
48.75
Previous Close
48.95
Day High
49.85
Day Low
48.50
52 Week High
02/25/14 - 51.50
52 Week Low
11/1/13 - 27.65
Market Cap
5.1B
Average Volume 10 Days
67.9K
EPS TTM
5.60
Shares Outstanding
103.1M
EX-Date
08/1/13
P/E TM
8.8x
Dividend
0.40
Dividend Yield
0.81%
Current Stock Chart for BLISS GVS PHARMA LTD (BLIS)

Related News

No related news articles were found.

bliss gvs pharma ltd (BLIS) Related Businessweek News

No Related Businessweek News Found

bliss gvs pharma ltd (BLIS) Details

Bliss GVS Pharma Limited engages in the manufacture and sale of branded generics, suppositories, soft pessaries, and women’s contraceptives in India and internationally. It offers prescription drugs, including antimalarial, anal suppositories, vaginal pessaries, and general products. The company also offers over the counter products, including Today, a vaginal contraceptive; and Maitri, a vaginal lubricant pessary. In addition, it offers pessary formulations, suppository formulations, calcium preparations, protein powders, iron preparations, antibiotics, analgesic and antipyretics, respiratory products, anti-inflammatory products, dermatological preparations, and anti-diarrhoeal products. Further, the company provides contract manufacturing services. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Founded in 1984

bliss gvs pharma ltd (BLIS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bliss gvs pharma ltd (BLIS) Key Developments

Bliss GVS Pharma Ltd Announces Board Changes

Bliss GVS Pharma Ltd. announced that Mrs. Sushma Yadav is appointed as a Company Secretary of the company on account of resignation of Mr. Amarendra Mohapatra.

Bliss Gvs Pharma Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended Dec. 31, 2013

Bliss Gvs Pharma Limited reported unaudited standalone earnings results for the third quarter and nine months ended Dec. 31, 2013. For the quarter, the company's net sales were INR 588.577 million compared to INR 813.168 million last year. Profit from operations before other income and finance cost and exceptional items was INR 180.682 million compared to INR 239.113 million last year. Profit form ordinary activities before tax INR 173.142 million compared to INR 241.991 million last year. Net profit after tax INR 106.284 million compared to INR 93.869 million last year. Basic and diluted EPS was INR 1.03, compared to INR 0.91 for the last year. For the nine months, the company's net sales were INR 2,297.612 million compared to INR 2,479.811 million last year. Profit from operations before other income and finance cost and exceptional items was INR 574.079 million compared to INR 809.876 million last year. Profit form ordinary activities before tax INR 780.640 million compared to INR 834.352 million last year. Net profit after tax INR 524.121 million compared to INR 509.778 million last year. Basic and diluted EPS was INR 5.06, compared to INR 4.94 for the last year.

Bliss Gvs Pharma Limited, Board Meeting, Feb 12, 2014

Bliss Gvs Pharma Limited, Board Meeting, Feb 12, 2014. Agenda: To consider unaudited standalone earnings results for the third quarter and nine months ended Dec. 31, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLIS:IN 49.10 INR 0.00

BLIS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLIS.
View Industry Companies
 

Industry Analysis

BLIS

Industry Average

Valuation BLIS Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLISS GVS PHARMA LTD, please visit www.blissgvspharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.